Jessica Lynn has an educational background in writing and marketing. She firmly believes in the power of writing in amplifying voices, and looks forward to doing so for the rare disease community.

    Early ERT Improves Pompe Disease Outcomes
    source: shutterstock.com

    Early ERT Improves Pompe Disease Outcomes

    Enzyme replacement therapy (ERT) is an approved treatment strategy for those with Pompe disease. It involves providing patients with alpha-glucosidase, which helps to break down glycogen. In addition to reducing…

    Continue Reading Early ERT Improves Pompe Disease Outcomes
    How Bridget Finn’s “FLOURISH” is Working to Eradicate STXBP1 (Pt. 1)
    The Finn Beaubien family, courtesy of Bridget Finn

    How Bridget Finn’s “FLOURISH” is Working to Eradicate STXBP1 (Pt. 1)

    “Together, we can do hard things.” That’s the mission of Clara Inspired, a nonprofit organization that aims to raise awareness and funds to cure genetic disorders like STXBP1 disorders. It’s…

    Continue Reading How Bridget Finn’s “FLOURISH” is Working to Eradicate STXBP1 (Pt. 1)